Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 5667 | Ordered by Source (descending)
1 2 3 ... 55 56 57  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme 2019-05-30
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-17
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Reaches New Milestone – Now more than 9,900 European Life Science Deals Available at Life-Sciences-Europe.com". Bremen. 2019-04-26
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
[iito] Business Intelligence. (7/15/20). "Press Release: [iito] Launches ADucation Campaign Summer 2020". Bremen. 2020-07-15
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
[iito] Business Intelligence. (5/4/20). "Press Release: [iito] Brings Back the Past into the [LSE] Newsletter". Bremen. 2020-05-04
[iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. 2020-12-10
[iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. 2020-11-08
[iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. 2020-11-30
[iito] Business Intelligence. (11/11/19). "Press Release: [iito] Launches Transatlantic Life Sciences Business Portal at BIO-Europe". Bremen & Hamburg. 2019-11-11
[iito] Business Intelligence. (10/31/18). "Press Release: [iito] Discontinues Life-Sciences-Spain.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2018-10-31
[iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2019-01-11
Zur Rose Group AG. (7/16/20). "Press Release: Zur Rose Group Acquires TeleClinic, Germany's Leading Telemedicine Provider". 2020-07-16
Zion Pharma Ltd.. (5/9/23). "Press Release: Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor". Hong Kong, Suzhou & Shanghai. 2023-05-09
Zhejiang Doer Biologics Co., Ltd.. (7/10/23). "Press Release: Doer Biologics Announces License Agreement with BioNTech". Hangzhou. 2023-07-10
Zetta Genomics Ltd.. (4/18/23). "Press Release: Zetta Genomics Secures £1.9 Million in Second Round Seed Funding to Configure for Scale, Delivery and Innovation". 2023-04-18
Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". 2024-02-08
Zetta Genomics Ltd.. (2/1/22). "Press Release: Zetta Genomics Gains £2.5m Seed Funding to Realise the Power of Genomic Data in Precision Medicine". New York, NY. 2022-02-01
Zelluna Immunotherapy AS. (6/25/19). "Press Release: Zelluna Immunotherapy Appoints Jens-Peter Marschner as Chief Medical Officer". Oslo. 2019-06-25
Zedira GmbH. (5/2/17). "Press Release: Dr. Falk Pharma and Zedira Announce Completion of Phase 1b Clinical Trial of ZED1227 for the Treatment of Celiac Disease and Move on to Proof of Concept Study". Freiburg & Darmstadt. 2017-05-02
Zedira GmbH. (4/26/18). "Press Release: Dr. Falk Pharma and Zedira Announce Start of the Phase 2a Proof of Concept Study of ZED1227 for the Treatment of Celiac Disease". Freiburg & Darmstadt. 2018-04-26
Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. 2017-07-03
Zambon Group. (7/25/19). "Press Release: Zambon Completes Transformational Acquisition of Breath Therapeutics". Milan. 2019-07-25
Zafrens. (12/11/23). "Press Release: Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale". San Diego, CA. 2023-12-11
Yumab GmbH. (7/22/19). "Press Release: Yumab Announces New Research and Collaboration Agreement with Merck". Braunschweig. 2019-07-22
Yumab GmbH. (7/19/23). "Press Release: Yumab and InScreeneX in Joint Funding Project". Braunschweig. 2023-07-19
Yumab GmbH. (6/16/20). "Press Release: Corat Therapeutics Takes Over the Fast Track Development of a Novel COVID-19 Antibody Drug Program". Braunschweig. 2020-06-16
Yumab GmbH. (5/7/20). "Press Release: Yumab Identifies Promising Candidate for Covid-19 Antibody Therapy". Braunschweig. 2020-05-07
Yukin Therapeutics SAS. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. 2019-06-04
Yokogawa Electric Corporation. (11/2/21). "Press Release: Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology". Tokyo. 2021-11-02
Ymmunobio AG. (6/16/22). "Press Release: Ymmunobio Signs Collaboration Agreement with Yumab". Riehen. 2022-06-16
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
XtalPi, Inc.. (10/24/18). "Press Release: XtalPi Announces the Closing of $46 Million Series B-1 Extension". Cambridge, MA. 2018-10-24
XPhyto Therapeutics Corporation. (7/20/21). "Press Release: XPhyto Signs Transformative Acquisition Agreement with 3a-Diagnostics, to Enter Hi-tech Biosensor Market and Expand Its Diagnostic Product Portfolio". Vancouver, BC & Frankfurt. 2021-07-20
Xoma Corporation. (8/25/17). "Press Release: Xoma Announces Transformational License Agreements for Gevokizumab and Its IL-1 beta Intellectual Property Portfolio". Berkeley, CA. 2017-08-25
XO Life GmbH. (2/16/22). "Press Release: Two Million Euros for XO Life GmbH’s Patient Insights Platform". Berlin & Munich. 2022-02-16
Xlife Sciences AG. (12/1/21). "Press Release: Xlife Sciences AG (XLS DE) Appoints New Chief Financial Officer". Zürich. 2021-12-01
Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. 2019-11-04
Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. 2022-11-21
Xlife Sciences AG. (1/10/22). "Press Release: Xlife Sciences Plans Listing on the »Sparks« Segment of SIX Swiss Exchange". Zürich. 2022-01-10
XL-protein GmbH. (7/26/17). "Press Release: Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation Technology to Develop Long-Acting Asparaginase Product Candidates". Freising. 2017-07-26
XL-protein GmbH. (1/9/18). "Press Release: Horizon Pharma plc and XL-protein GmbH Have Entered Into a Collaboration Agreement on a Potential Next-Generation Biologic for Uncontrolled Gout Using PASylation Technology". Freising. 2018-01-09
Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. 2017-01-05
Xencor, Inc.. (2/5/19). "Press Release: Xencor to Develop and Commercialize Novel IL-15 Immune Activating Cytokines with Genentech". Monrovia, CA. 2019-02-05
Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. 2019-01-07
Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven. 2017-11-15
Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA". 2017-01-31
XAnge (Alexis du Peloux). (3/29/22). "Press Release (Blog Post): Core Biogenesis – When a Deeptech Goes Faster than Eexpected, Let’s Speed Up!". 2022-03-29
X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. 2019-07-01
WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. 2024-01-11
WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. 2023-11-28
Wise S.r.l.. (5/25/17). "Press Release: Wise Srl Raises EUR 6.5 Million for Clinical Validation of Novel Neuroelectrodes for Brain Monitoring and Spinal Cord Stimulation". Milan & Berlin. 2017-05-25
Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. 2017-07-13
Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. 2017-06-19
Wilex AG. (4/24/17). "Press Release: Wilex AG Plans Rights Issue Using Authorised Capital. Ad-hoc release [Not for distribution, publication or transmission in the USA, Canada, Japan and Australia]". Munich. 2017-04-24
Wilex AG. (4/12/17). "Press Release: Interim Management Statement on the First Three Months of 2017". Munich. 2017-04-12
Wilex AG. (2/6/17). "Press Release: Wilex AG Secures Financing Commitment from Its Main Shareholder Dievini". Munich. 2017-02-06
Wilex AG. (10/9/17). "Press Release: Wilex AG Announces Adjustment of Guidance [Ad-hoc release – Insider information pursuant to Article 17 MAR]". Ladenburg. 2017-10-09
Wilex AG. (10/9/17). "Press Release: Interim Management Statement for the First Nine Months of 2017". Munich. 2017-10-09
Wilex AG. (1/25/17). "Press Release: Subsidiary Heidelberg Pharma Exercises Option on BCMA Antibodies of the Max Delbrück Center and Signs License Agreement". Munich. 2017-01-25
Werum IT Solutions AG. (5/16/19). "Press Release: Jens Woehlbier Assigned as New CEO of Werum IT Solutions". Lüneburg. 2019-05-16
Werum IT Solutions AG. (3/1/17). "Press Release: Werum America Reinforces Key Account Relations with Experienced Pharma Manufacturing Specialist". Lüneburg & Parsippany, NJ. 2017-03-01
Wellington Partners. (7/31/19). "Press Release: Wellington Partners Raises EUR 210 Million Life Science Fund". 2019-07-31
Wellington Partners. (1/8/20). "Press Release: Karl Naegler Joins Wellington Partners as Managing Partner". Munich. 2020-01-08
Waters Corporation. (7/15/20). "Press Release: Waters Corporation Names Udit Batra President and Chief Executive Officer. Announces Preliminary Second Quarter 2020 Sales". Milford, MA. 2020-07-15
Waters Corporation. (6/5/23). "Press Release: Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing". Milford, MA & Göttingen. 2023-06-05
Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. 2017-06-22
Waters Corporation. (6/1/18). "Press Release: Waters Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018". Milford, MA. 2018-06-01
Waters Corporation. (4/10/18). "Press Release: Waters New Acquity UPLC Plus Series Sets New Performance Benchmarks". Milford, MA. 2018-04-10
Waters Corporation. (10/27/21). "Press Release: Waters and Sartorius Partner to Help Bioprocess Scientists Accelerate Clone Selection and Process Development". Milford, MA & Göttingen. 2021-10-27
Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. 2020-01-13
Warp Drive Bio, Inc.. (10/16/17). "Press Release: Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections". Cambridge, MA. 2017-10-16
Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. 2018-09-13
Wacker Chemie AG. (7/5/22). "Press Release: Wacker to Start Construction of Competence Center for mRNA Actives at Halle Site". Tübingen & Boston, MA. 2022-07-05
Wacker Chemie AG. (7/28/20). "Press Release: Wacker Invests in Amsterdam Biotech Site". Munich & Amsterdam. 2020-07-28
Wacker Chemie AG. (6/2/22). "Press Release: Wacker to Invest Double-Digit Million-Euro Sum in Biotechnology Center". Munich. 2022-06-27
Wacker Chemie AG. (5/8/23). "Press Release: Wacker Purchases ADL BioPharma in Spain, Strengthening Its Biotechnology Business". Munich & León. 2023-05-08
Wacker Chemie AG. (3/8/17). "Press Release: Wacker Biotech and Fresenius Medical Care Successfully Produce Antibody Fragment with Foldtec". Munic & Jena. 2017-03-08
Wacker Chemie AG. (2/3/21). "Press Release: Wacker Strengthens Biologics Business by Acquiring US-based Plasmid DNA Manufacturer Genopis". Munich & San Diego, CA. 2021-02-03
Wacker Chemie AG. (12/8/21). "Press Release: Aleph Farms and Wacker Develop Open Supply Chain Solution for Proteins Used in Large-Scale Production of Cultivated Meat". Munich & Rehovot. 2021-12-08
Wacker Chemie AG. (12/14/21). "Press Release: Wacker and CordenPharma Develop Solutions for Formulating Lipid Nanoparticles Expanding Their Portfolio for Advanced Medicines". Munich & Luxembourg. 2021-12-14
Wacker Chemie AG. (10/12/22). "Press Release: Neuway Pharma and Wacker Launch Research Project to Develop RNA-Based Actives for the Treatment of Central Nervous System Diseases". Munich & Bonn. 2022-10-12
Wacker Chemie AG. (1/17/22). "Press Release: Plasmitec – Wacker Introduces Its Plasmid DNA Production Platform". Munich & San Diego, CA. 2022-01-17
Wacker Chemie AG. (1/11/22). "Press Release: Wacker and Biosyntia Develop Large-Scale Production Process for Sustainable Biotin". Munich & Copenhagen. 2022-01-11
Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. 2019-01-22
Vor Biopharma, Inc.. (2/14/19). "Press Release: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia". Boston, MA. 2019-02-14
Voluntis S.A.. (3/4/20). "Press Release: Voluntis Announces Its New Strategic Roadmap. Strategic Prioritization of the Oncology Business". Cambridge, MA & Paris. 2020-03-04
Voluntis S.A.. (12/18/19). "Press Release: Voluntis Announces New Pharma Collaboration in Oncology". Cambridge, MA & Paris. 2019-12-18
Voluntis S.A.. (11/23/20). "Press Release: Voluntis Successfully Completes a Capital Increase of €5.9 Million and Finalizes the Financing of Its Strategic Roadmap [Not for US, CA, AU or JP] Japan.". Cambridge, MA & Paris. 2020-11-23
Volumina Medical SA. (3/25/24). "Press Release: Volumina Medical Secures USD 21 Million Funding to Continue Its Clinical Program after Having Obtained Promising First in Human Data". Epalinges. 2024-03-25
Vivoryon Therapeutics N.V.. (6/29/21). "Press Release: Vivoryon Therapeutics and Simcere Announce Strategic Regional Licensing Partnership to Develop and Commercialize N3pE Amyloid-targeting Medicines to Treat Alzheimer's Disease in Greater China". Halle 2021-06-29
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). 2019-08-29
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). 2019-10-08
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Vivlion GmbH. (5/11/23). "Press Release: Vivlion to Provide Services to Repare Therapeutics on Advanced PRCISR CRISPR gRNA Libraries". Frankfurt. 2023-05-11
Vividion Therapeutics, Inc.. (5/19/20). "Press Release: Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases". San Diego, CA. 2020-05-19
Vividion Therapeutics, Inc.. (4/30/19). "Press Release: Vividion Therapeutics Announces Oversubscribed $82 Million Series B Financing". San Diego, CA. 2019-04-30
Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA. 2021-02-24
Vivet Therapeutics SAS. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. 2017-05-04
1 2 3 ... 55 56 57  next pagenext page



Advertisement

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Top News New Ariceum Radiopharma Lab 650x300px

» top